Collectively, these data are consistent with a separation of a T790M clone and a SCLC clone from a common founder LAC clone during the branching clonal evolution of EGFRM+ LAC described by Lee et al. [200]. The gene discussed is LCT; the disease is small cell lung carcinoma.